- Home
- IVD
- By Technology Types
- By Diseases Types
- By Product Types
- Research
- Resource
- Distributors
- Company
| Product Name | BCR-ABL P210 Gene Quantification Kit (Fluorescent PCR Method) |
| Catalog No. | BDDK-HMM-0019 |
| Description | Ph chromosome or BCR/ABL1 b2a2 and b3a2 types have become the main diagnostic criteria for CML, with ela2 predominantly seen in ALL. In 55% of CML cases b3a2 type and 40% b2a2 type. In 5% of cases both b3a2 and b2a2 type spliceosomes are present. In addition, the BCR/ABL1 fusion gene type e19a2 is present in a very small number of Ph+ CML patients, the BCR/ABL1 fusion gene is type P210 in 30-50% of adult Ph+ ALL, 20-30% of pediatric Ph+ ALL cases, and the BCR/ABL1 fusion gene is type P190 in 60% of Ph+ ALL patients. |
| Disease Type | Leukaemia |
| Applications | This kit is for the quantitative detection of BCR-ABL1 fusion gene P210 (e13a2 and e14a2) type by fluorescence quantitative PCR. |
| Sample Type | Peripheral blood |
| Detection Methods | Fluorescent PCR Method |
| Storage | -20°C |
For research use only, not for clinical use.
|
There is no product in your cart. |